Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004907.pdf 0001562180-24-004907.rtf 0001562180-24-004907.xls View HTML
June 10, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004910.pdf 0001562180-24-004910.rtf 0001562180-24-004910.xls View HTML
May 14, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004025.pdf 0001562180-24-004025.rtf 0001562180-24-004025.xls View HTML
May 14, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-004026.pdf 0001562180-24-004026.rtf 0001562180-24-004026.xls View HTML
May 13, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000052.pdf 0001517022-24-000052.rtf 0001517022-24-000052.xls View HTML
May 13, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000051.pdf 0001517022-24-000051.rtf 0001517022-24-000051.xls View HTML
May 9, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000050.pdf 0001517022-24-000050.rtf 0001517022-24-000050.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 9, 2024	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-24-021945.pdf 0001628280-24-021945.rtf 0001628280-24-021945.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 9, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-003948.pdf 0001562180-24-003948.rtf 0001562180-24-003948.xls View HTML
April 25, 2024	DEFA14A	Additional proxy soliciting materials - definitive	0001517022-24-000046.pdf 0001517022-24-000046.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax